Search
for
Did you mean laboratory tests?
Products matching "laboratory test"
Tracking 5 products like 255 RU58841 8% PG+ Ethanol, 256 RU58841 8% KB solution, 258 RU58841 5% + KB solution, 260 RU58841 Powder and 260 RU58841 Powder from by companies like Anageninc. View all 5 products »Research
5 / 1000+ results![Laboratory Testing in Telogen Effluvium](/images/research/fffbebbd-d942-41c4-84ec-3d2e2719f084/small/23903.jpg)
research Laboratory Testing in Telogen Effluvium
The document concludes that more research is needed to confirm if blood tests for things like iron and vitamin D are helpful for hair loss from Telogen effluvium.
![Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane](/images/research/225157e6-4047-4807-b4a4-03b03f08468b/small/27616.jpg)
research Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane
Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.
![Utility of laboratory testing in patients with female pattern hair loss](/images/research/81af55e5-e46c-42a2-b67a-3f3d7e9b075d/small/4579.jpg)
research Utility of laboratory testing in patients with female pattern hair loss
Lab tests for female hair loss have unclear usefulness; consider based on symptoms.
![High-value dermatology: 5 Laboratory tests to reconsider](/images/research/588e41b8-182a-466f-9d5c-00c88c8bcadc/small/13712.jpg)
research High-value dermatology: 5 Laboratory tests to reconsider
The article suggests that five common skin-related lab tests may be unnecessary and could cause extra cost and anxiety without improving patient care.
![“Shedding” low yield testing for telogen effluvium: A cross-sectional study of 16,381 laboratory results from newly diagnosed patients](/images/research/569f6106-85dc-4699-b946-fd66757d5a66/small/23521.jpg)
research “Shedding” low yield testing for telogen effluvium: A cross-sectional study of 16,381 laboratory results from newly diagnosed patients
Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.
Community Join
5 / 37 resultscommunity CB-03-01: I need help
The user stopped using finasteride and RU58841 and is considering CB-03-01 for androgenic alopecia but is concerned about the cost and effectiveness, especially at a lower dose than in clinical trials. They are also using minoxidil, micro-needling, and nizoral shampoo but are unsure about the correct application method for CB-03-01.
community I’m on a crazy hairloss stack and I’m still losing hair and not experiencing any regrowth. What is going on?
The user is using a combination of hair loss treatments including finasteride, stemoxydine, oral minoxidil, RU58841, dermastamping, ketoconazole shampoo, collagen, Viviscal, and biotin, and has improved their diet. Despite these efforts, they are still experiencing hair shedding and scalp itchiness, and are considering increasing their minoxidil dosage or starting dutasteride.
community AnagenInc says GT20029 is possible now
AnagenInc is ready to produce a hair loss treatment called GT20029 if there is enough demand. People are discussing combining it with other treatments like finasteride and minoxidil, and some are concerned about the legitimacy and safety of gray market products.
community Whoever had success with PYRILUTAMIDE, please give us hope outside of 5AR inhibitors.
Users discuss using pyrilutamide for hair loss, seeking alternatives to 5AR inhibitors. They mention using minoxidil, ketoconazole shampoo, and RU58841.
community FCE 28260: A Forgotten 5α-Reductase Inhibition
FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.